INI. G. Nasretdinova

I. G. Nasretdinova

*This is an algorithmically generated author record based on publicly available information.

I. G. Nasretdinova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of insulin resistance based on the estimated rate of glucose utilization among adult patients with type 1 diabetes and its role in predicting diabetic complications

    by R. I. Malievskaya, D. S. Avzaletdinova, O. A. Malievskiy, I. G. Nasretdinova, A. Z. Bulgakova, P. S. Guseva, A. D. Nasyrtdinova, A. M. Absalyamova, T. V. Morugova

    BACKGROUND: The significance of determining insulin resistance (IR) in people with type 1 diabetes mellitus (T1DM) is determined by the acceleration of the transition from the first stage of development of T1DM to the second and third, and is also a risk factor for the development of chronic complications of diabetes. The lack of a unified criterion for determining metabolically significant insulin resistance in patients with T1DM determines the need to study this problem.AIM: To study the incidence of insulin resistance in individuals with T1DM over 18 years of age and disease duration of more than 1 year based on the estimated rate of glucose utilization and to determine the association between the eGDR value MATERIALS AND METHODS: 201 patients with T1DM over 18 years of age and T1DM duration of more than 1 year were examined. Among them, 95 (47%) were men, 106 (53%) were women. Median age was 30.0 [28.1; 33.0] years, median duration of T1DM — 13 [12; 15] years. The estimated rate of glucose utilization was estimated using the equation of Williams K. et al. (2000). Patients with an eGDR value RESULTS: The value of eGDR CONCLUSION: The fairly high prevalence of IR among patients with type 1 diabetes, the risk of developing diabetic nephropathy and atherosclerosis of the arteries of the lower extremities in these individuals, justifies the need to identify this condition in clinical practice in order to improve the course of type 1 diabetes.

  • Open Access

    Metabolic syndrome in type 1 diabetes mellitus in adults

    by R. I. Malievskaya, D. S. Avzaletdinova, I. G. Nasretdinova, I. Z. Urmanova, D. F. Iksanova

    Background. The prevalence of metabolic syndrome (MS) among people with type 1 diabetes mellitus (T1DM) varies widely depending on the criteria used and ranges from 6.4 to 57%. The relevance of studying the MS in T1DM is caused by the high risk of developing of micro and macrovascular complications. The current criteria for MS and the controversy over the inclusion of T1DM as a criterion do not provide reliability in diagnosing MS in this disease.The aim. To assess the prevalence of MS in adults with T1DM and its impact on the course of the disease.Materials and methods. A total of 134 patients over the age of 18 years were studied, including 67 (50%) men and 67 (50%) women. The median age was 33[19; 43] years, the median duration of diabetes was 13 [4; 27] years. MS was assessed according to the criteria of the 2009 Joint Interim Statement (JIS).Results. MS was detected in 34 (25.4%) patients. The number of patients who did not have other criteria for MS except for T1DM was 57 (42.5%), 43 (32.1%) patients had 2 components of MS (one of the components in all was diabetes). Waist circumference >94 cm in men and > 80 cm in women, as well as blood pressure > 130 and 85 mm Hg were the most common components of MS (73.5 and 70.6% respectively). The insulin sensitivity coefficient was significantly lower in the group of people with MS (p=0.012). In patients with MS, only diabetic nephropathy was significantly more common (p = 0.019), while the differences in the frequency of retinopathy and neuropathy were statistically insignificant.Conclusion. MS is a common condition in T1DM, which is based on insulin resistance. Presence of MS is associated with a risk of developing of diabetic nephropathy.